ALDER BIOPHARMACEUTICALS INC - NOTE 2.500% 2/0

CUSIP: 014339AA3

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Debt / NOTE 2.500% 2/0
Market price (% of par)
107.24%
Total 13F principal
$281,388,000
Principal change
+$3,515,000
Total reported market value
$302,103,509
Number of holders
30
Value change
+$3,918,963
Number of buys
9
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 014339AA3?
CUSIP 014339AA3 identifies 014339AA3 - ALDER BIOPHARMACEUTICALS INC - NOTE 2.500% 2/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ALDER BIOPHARMACEUTICALS INC - NOTE 2.500% 2/0 as of Q3 2018

As of 30 Sep 2018, ALDER BIOPHARMACEUTICALS INC - NOTE 2.500% 2/0 was held by 30 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $281,388,000 in principal (par value) of the bond. The largest 10 bondholders included Partner Fund Management, L.P., WOLVERINE ASSET MANAGEMENT LLC, Linden Advisors LP, Redmile Group, LLC, CITADEL ADVISORS LLC, Lion Point Capital, LP, AMUNDI PIONEER ASSET MANAGEMENT INC, Allianz Asset Management GmbH, AMERIPRISE FINANCIAL INC, and CREDIT SUISSE AG/. This page lists 30 institutional bondholders reporting positions for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.